SOAR: Study Observing Antiarrhythmic Remodelling Using LGE-MRI.
Phase of Trial: Phase III
Latest Information Update: 21 Feb 2016
At a glance
- Drugs Dronedarone (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms SOAR
- 28 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Sep 2011 Planned end date changed from 1 Aug 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 03 Sep 2010 New trial record